61 related articles for article (PubMed ID: 8197034)
1. Symptomatology, pulmonary function and response, and T lymphocyte beta 2-receptors during smoking cessation in patients with chronic obstructive pulmonary disease.
Leader WG; Wolf KM; Cooper TM; Chandler MH
Pharmacotherapy; 1994; 14(2):162-72. PubMed ID: 8197034
[TBL] [Abstract][Full Text] [Related]
2. Premenstrual asthma: the effect of estrogen on symptoms, pulmonary function, and beta 2-receptors.
Chandler MH; Schuldheisz S; Phillips BA; Muse KN
Pharmacotherapy; 1997; 17(2):224-34. PubMed ID: 9085312
[TBL] [Abstract][Full Text] [Related]
3. Nicotine patch therapy in 101 adolescent smokers: efficacy, withdrawal symptom relief, and carbon monoxide and plasma cotinine levels.
Hurt RD; Croghan GA; Beede SD; Wolter TD; Croghan IT; Patten CA
Arch Pediatr Adolesc Med; 2000 Jan; 154(1):31-7. PubMed ID: 10632247
[TBL] [Abstract][Full Text] [Related]
4. Nicotine metabolite ratio predicts efficacy of transdermal nicotine for smoking cessation.
Lerman C; Tyndale R; Patterson F; Wileyto EP; Shields PG; Pinto A; Benowitz N
Clin Pharmacol Ther; 2006 Jun; 79(6):600-8. PubMed ID: 16765148
[TBL] [Abstract][Full Text] [Related]
5. Terbutaline serum concentrations related to different lung function parameters and beta-receptor function.
van den Berg W; Leferink JG; Tabingh Suermondt W; Kreukniet J; Maes RA; Serra R; Bruynzeel PL
Int J Clin Pharmacol Ther Toxicol; 1983 Jan; 21(1):24-30. PubMed ID: 6299982
[TBL] [Abstract][Full Text] [Related]
6. In vivo and in vitro beta 2-adrenergic receptor responsiveness in young and elderly asthmatics.
Hamelin BA; Blouin RA; Wolf KM; Clifton GD; Chandler MH
Pharmacotherapy; 1992; 12(5):376-82. PubMed ID: 1331993
[TBL] [Abstract][Full Text] [Related]
7. Smoking cessation advice for patients with chronic periodontitis.
Nasry HA; Preshaw PM; Stacey F; Heasman L; Swan M; Heasman PA
Br Dent J; 2006 Mar; 200(5):272-5; discussion 265. PubMed ID: 16528334
[TBL] [Abstract][Full Text] [Related]
8. [Success of smoking cessation in patients with chronic obstructive pulmonary disease].
Aytemur Solak Z; Başoğlu OK; Erdinç E
Tuberk Toraks; 2006; 54(1):43-50. PubMed ID: 16615017
[TBL] [Abstract][Full Text] [Related]
9. Nicotine patch therapy in adolescent smokers.
Smith TA; House RF; Croghan IT; Gauvin TR; Colligan RC; Offord KP; Gomez-Dahl LC; Hurt RD
Pediatrics; 1996 Oct; 98(4 Pt 1):659-67. PubMed ID: 8885942
[TBL] [Abstract][Full Text] [Related]
10. Effect of nicotine lozenges on affective smoking withdrawal symptoms: secondary analysis of a randomized, double-blind, placebo-controlled clinical trial.
Shiffman S
Clin Ther; 2008 Aug; 30(8):1461-75. PubMed ID: 18803988
[TBL] [Abstract][Full Text] [Related]
11. The effect of a minimal contact smoking cessation programme in out-patients with chronic obstructive pulmonary disease: a pre-post-test study.
Monninkhof E; van der Valk P; van der Palen J; Mulder H; Pieterse M; van Herwaarden C; Zielhuis G
Patient Educ Couns; 2004 Mar; 52(3):231-6. PubMed ID: 14998591
[TBL] [Abstract][Full Text] [Related]
12. Declining FEV1 and chronic productive cough in cigarette smokers: a 25-year prospective study of lung cancer incidence in Tecumseh, Michigan.
Islam SS; Schottenfeld D
Cancer Epidemiol Biomarkers Prev; 1994 Jun; 3(4):289-98. PubMed ID: 8061576
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of bupropion and nortriptyline for smoking cessation among people at risk for or with chronic obstructive pulmonary disease.
Wagena EJ; Knipschild PG; Huibers MJ; Wouters EF; van Schayck CP
Arch Intern Med; 2005 Oct; 165(19):2286-92. PubMed ID: 16246996
[TBL] [Abstract][Full Text] [Related]
14. [The changes in beta-adrenergic receptors and cyclic AMP levels of lymphocytes in patients with COPD].
Gao DW
Zhonghua Jie He He Hu Xi Za Zhi; 1989 Feb; 12(1):27-9, 62. PubMed ID: 2567638
[TBL] [Abstract][Full Text] [Related]
15. Effects of 24-hr nicotine replacement on sleep and daytime activity during smoking cessation.
Wolter TD; Hauri PJ; Schroeder DR; Wisbey JA; Croghan IT; Offord KP; Dale LC; Hurt RD
Prev Med; 1996; 25(5):601-10. PubMed ID: 8888329
[TBL] [Abstract][Full Text] [Related]
16. The beta-adrenergic system of non-allergic patients with chronic airflow obstruction and early morning dyspnoea.
Meurs H; Postma DS; Koëter GH; Keyzer JJ; Timmermans A; Kauffman HF; de Vries K
Ann Allergy; 1987 Dec; 59(6):417-21. PubMed ID: 2827542
[TBL] [Abstract][Full Text] [Related]
17. Smoking cessation increases gingival blood flow and gingival crevicular fluid.
Morozumi T; Kubota T; Sato T; Okuda K; Yoshie H
J Clin Periodontol; 2004 Apr; 31(4):267-72. PubMed ID: 15016254
[TBL] [Abstract][Full Text] [Related]
18. Influence of smoking cessation on airway T lymphocyte subsets in COPD.
Roos-Engstrand E; Ekstrand-Hammarström B; Pourazar J; Behndig AF; Bucht A; Blomberg A
COPD; 2009 Apr; 6(2):112-20. PubMed ID: 19378224
[TBL] [Abstract][Full Text] [Related]
19. Does additional support by nurses enhance the effect of a brief smoking cessation intervention in people with moderate to severe chronic obstructive pulmonary disease? A randomised controlled trial.
Wilson JS; Fitzsimons D; Bradbury I; Stuart Elborn J
Int J Nurs Stud; 2008 Apr; 45(4):508-17. PubMed ID: 17184783
[TBL] [Abstract][Full Text] [Related]
20. Prediction of abstinence at 10 weeks based on smoking status at 2 weeks during a quit attempt: secondary analysis of two parallel, 10-week, randomized, double-blind, placebo-controlled clinical trials of 21-mg nicotine patch in adult smokers.
Ferguson SG; Gitchell JG; Shiffman S; Sembower MA
Clin Ther; 2009 Sep; 31(9):1957-65. PubMed ID: 19843485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
